A PRPH2 gene variant detected in retinitis punctata albescens with congenital hypertrophy of the retinal pigment epithelium. Issue 1 (January 2022)

• Record Type: Journal Article
• Authors: Qiu, Aowang; Yu, Yan; Huang, Junlong; Liu, Qinghuai; Paulus, Yannis M; Fan, Wen
• Is Part Of: European journal of ophthalmology. Volume 32:Issue 1(2022)
• Page Start: NP134
• Page End: NP138
• Publication Date: 2022-01
• Subjects: Congenital and stationary retinal disease -- RETINA -- genetics -- electrophysiology -- retinitis pigmentosa -- techniques of retinal examination; Ophthalmology -- Periodicals; Eye -- Diseases -- Periodicals; 617.7005
• DOI: 10.1177/1120672120962027
• Languages: English
• ISSNs: 1120-6721

Abstract

Retinitis punctata albescens (RPA) is generally diagnosed by the presence of numerous clusters of white punctate lesions in the retina that progress over time and are related to several gene variants. The multifocal variant of congenital hypertrophy of the retinal pigment epithelium (CHRPE) is characterized by multiple, grouped, sharply circumscribed, pigmented spots. The PRPH2 gene encodes a photoreceptor-specific glycoprotein, which is essential for the morphogenesis of rod and cone photoreceptor outer segments. A 39-year-old Chinese female with nyctalopia, complained about blurred vision, presented a unique co-existing feature of RPA and CHRPE. Dilated fundus exam demonstrated numerous porcelain white discrete dots in both eyes and multiple, small, flat clusters of round brown to black pigmented lesions in the left eye. The full field electroretinography (ERG) showed decreased responses after standard dark adaptation and normal b-wave amplitudes after a long (4-h) dark-adapted period. A heterozygous PRPH2 splicing variant was detected in the proband. In addition, the same variant was found in her mother, her son, and her daughter. We describe a PRPH2 variant in a rare case of RPA associated with multifocal CHRPE of the same individual.